The RSV shot isn't suggested for everyone like the flu vaccine is. Here's who is at risk and how to get a shot.

As the leaves begin to change and the temperature starts to cool, families are reminded of respiratory syncytial virus (RSV) ...

Because babies have immature immune systems and tiny airways, RSV (respiratory syncytial virus) can be a bigger risk for them than it is for older children and adults, causing the lung infection ...

Two new studies suggest that nirsevimab (Beyfortus) is 80% to 89% effective in protecting infants from poor respiratory ...

The Centers for Disease Control and Prevention have issued a new recommendation to protect babies against RSV. According to the updated guidelines, infants under the age of 8 months should receive a ...

A pooled multicountry analysis shows that immunisation with nirsevimab effectively reduced RSV-related hospitalisation in ...

More hard-to-find doses of Beyfortus, the new immunization against respiratory syncytial virus (RSV) for infants, will be available in January, the White House says. The announcement comes as RSV ...

Nirsevimab is a long-acting monoclonal antibody that provides season-long protection against RSV in infants, reducing ...

Researchers found differences in how respiratory syncytial virus spreads among children in rural versus urban communities and ...

This follows the US Food and Drug Administration’s (FDA) call to hit pause on all RSV vaccine trials involving infants or RSV ...

An infant immunization for respiratory syncytial virus (RSV) is now available across Canada, but it still has to be paid for ...